Research
Lake Street Initiates Aligos Therapeutics With Buy Rating, $45 Price Target
Aligos Therapeutics (ALGS) has an average rating of Buy and mean price target of $56.29, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$ALGS
